stoxline Quote Chart Rank Option Currency Glossary
  
TELA Bio, Inc. (TELA)
5.67  0.06 (1.07%)    03-28 16:00
Open: 5.64
High: 5.78
Volume: 80,931
  
Pre. Close: 5.61
Low: 5.57
Market Cap: 140(M)
Technical analysis
2024-03-28 4:54:37 PM
Short term     
Mid term     
Targets 6-month :  7.52 1-year :  8.38
Resists First :  6.43 Second :  7.17
Pivot price 5.49
Supports First :  5.23 Second :  4.35
MAs MA(5) :  5.6 MA(20) :  5.78
MA(100) :  6.14 MA(250) :  7.98
MACD MACD :  -0.3 Signal :  -0.4
%K %D K(14,3) :  30.3 D(3) :  24.1
RSI RSI(14): 43.6
52-week High :  11.6 Low :  4.23
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TELA ] has closed below upper band by 19.3%. Bollinger Bands are 58.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.79 - 5.81 5.81 - 5.83
Low: 5.51 - 5.54 5.54 - 5.56
Close: 5.63 - 5.67 5.67 - 5.71
Company Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Headline News

Wed, 27 Mar 2024
TELA Bio launches liquid adhesive in the US - Medical Plastics News

Sun, 24 Mar 2024
Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their ... - Simply Wall St

Sun, 24 Mar 2024
Analysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Results - Yahoo Finance

Sun, 24 Mar 2024
TELA Bio (NASDAQ:TELA) Rating Reiterated by JMP Securities - Defense World

Fri, 22 Mar 2024
Tela Bio Inc Up 9.44% To $5.86 After Earnings Miss - InvestorsObserver

Fri, 22 Mar 2024
TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 24 (M)
Shares Float 16 (M)
Held by Insiders 2.6 (%)
Held by Institutions 87.6 (%)
Shares Short 662 (K)
Shares Short P.Month 705 (K)
Stock Financials
EPS -2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.76
Profit Margin -79.9 %
Operating Margin -72.3 %
Return on Assets (ttm) -37.8 %
Return on Equity (ttm) -281.3 %
Qtrly Rev. Growth 46.2 %
Gross Profit (p.s.) 0
Sales Per Share 2.38
EBITDA (p.s.) -1.77
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -2.85
PEG Ratio 0
Price to Book value 7.36
Price to Sales 2.37
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android